<it>SMN1 </it>dosage analysis in spinal muscular atrophy from India
<p>Abstract</p> <p>Background</p> <p>Spinal muscular atrophy (SMA) represents the second most common fatal autosomal recessive disorder after cystic fibrosis. Due to the high carrier frequency, the burden of this genetic disorder is very heavy in developing countries li...
Saved in:
Main Authors: | Leonard Debra GB (Author), Rennert Hanna (Author), Kesari Akanchha (Author), Mittal Balraj (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2005-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Melissa Bowerman, et al.
Published: (2017) -
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Audrey M. Winkelsas, et al.
Published: (2021) -
Molecular-genetic study of <i>SMN1</i> and <i>SMN2</i> genes associated with spinal muscular atrophy in individuals with infertility prior to in vitro fertilization
by: E. V. Kudryavtseva, et al.
Published: (2024) -
Mutational analysis of SMN gene in patients with spinal muscular atrophy and the correlation between mutation and the severity of clinical manifestations
by: Almagul Nagimtaeeva, et al.
Published: (2017) -
Genetic and expression studies of <it>SMN2 </it>gene in Russian patients with spinal muscular atrophy type II and III
by: Schiöth Helgi B, et al.
Published: (2011)